Clinical Trial Update: Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the effectiveness of AZT and nevirapine in preventing HIV transmission from HIV-positive mothers to their newborns.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• AZT (zidovudine)
• NEVIRAPINE (nevirapine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED